Association between Pioglitazone and Bladder Cancer in a Medicare population

First published 26/04/2016

Last updated 27/03/2024

EU PAS number:

EUPAS13279

Study

Planned

Download as PDF

Documents

Study protocol

Initial protocol

PioBladderCancer_SafetyProtocol_ENCePPv25Apr2016

English (237.74 KB - PDF) View document

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Association between Pioglitazone and Bladder Cancer in a Medicare population

Secondary tabs

Share this page